Suchergebnisse - "D'Arienzo, Paolo D"

PubPharm (6)

1

Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery : a multicenter, retrospective cohort study

enthalten in: EClinicalMedicine | 2024

von Bai, X. | Shaheen, A. | Grieco, C. | +43

ErratumFor: EClinicalMedicine. 2023 Oct 31;65:102290. - PMID 37965433

2

Salvage Therapy With Selpercatinib for RET-Rearranged NSCLC With Pralsetinib-Related Pneumonitis and Leptomeningeal Disease : A Case Report

enthalten in: JTO clinical and research reports | 2023

von d'Arienzo, P. | Cunningham, N. | O'Sullivan, H. | +3

3

Measuring the Invisible : Circulating Tumor DNA as a Predictive and Prognostic Marker of Response to Adjuvant Chemotherapy in Resected Colorectal Cancer

enthalten in: Gastroenterology | 2023

von D'Arienzo, P. | Pinato, D.

4

Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery : a multicenter, retrospective cohort study

enthalten in: EClinicalMedicine | 2023

von Bai, X. | Shaheen, A. | Grieco, C. | +43

ErratumIn: EClinicalMedicine. 2024 Mar 27;71:102564. - PMID 38572079

5

Response to letter entitled : Re: 'Inadequacy of PCR genotyping in advanced non-small cell lung cancer: EGFR L747_A755delinsSS exon 19 deletion is not detected by the real-time PCR IdyllaTM EGFR mutation test but is detected by ctDNA NGS and responds to osimertinib': Not looking back

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von O'Sullivan, H. | d'Arienzo, P. | Yousaf, N. | +2

CommentOn: Eur J Cancer. 2022 May;166:38-40. - PMID 35276501

6

Inadequacy of PCR genotyping in advanced non-small cell lung cancer : EGFR L747_A755delinsSS exon 19 deletion is not detected by the real-time PCR Idylla™ EGFR mutation test but is detected by ctDNA next generation sequencing and responds to osimertinib

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von O'Sullivan, H. | d'Arienzo, P. | Yousaf, N. | +2

CommentIn: Eur J Cancer. 2022 Oct;174:315-317. - PMID 35934607

1
[1]